Loading organizations...
Enhatch is a Hoboken, New Jersey-based healthcare technology company that develops AI-powered software solutions for surgical planning and patient-specific medical device workflows. The company's platform utilizes artificial intelligence to automatically segment imaging scans and generate three-dimensional models, streamlining the design and manufacturing of customized implants and surgical guides. Operating with a total workforce of 26 employees, the enterprise generates approximately $7.4 million in annual revenue through its specialized orthopedic and spine surgery applications. To support its clinical operations, the firm maintains HIPAA and HITECH compliance across its digital infrastructure. Enhatch maintains a strategic partnership with investor 3D Systems to provide end-to-end printing services, while serving major medical device manufacturers including Smith + Nephew. The company was founded in 2012 by industry executives with prior leadership experience at Stryker Orthopedics and Tornier.
Enhatch has raised $9.0M across 1 funding round.
Enhatch has raised $9.0M in total across 1 funding round.
Enhatch has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Series A in June 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2021 | $9M Series A | — | Apis Holdings | Announced |
Enhatch has raised $9.0M in total across 1 funding round.
Enhatch's investors include Apis Holdings.
Enhatch is a medical technology company founded in 2012 that develops the Intelligent Surgery Ecosystem, an AI-powered, cloud-based platform for virtual surgical planning, particularly for orthopedic and spine procedures using 3D printed implants and guides.[1][2][6] It serves medical device manufacturers, hospitals, surgeons, and distributors by streamlining patient-specific implant design, preoperative planning, workflow automation, and integration with technologies like navigation, robotics, and additive manufacturing, solving inefficiencies in case planning, inventory management, and logistics to enable faster, safer surgeries.[1][2][3][6] With venture backing from investors like Numeta Capital, Apis Holdings, and Riverside Acceleration Capital, Enhatch reports $7.4 million in revenue and maintains FDA-registered, ISO 13485-certified facilities, recently securing FDA 510(k) clearance for its AI-driven patient-specific instrumentation in total knee arthroplasty.[1][3][4][7] Growth momentum includes partnerships like with 3D Systems for end-to-end plan-and-print services and scalable adoption for high-volume surgeons.[1][5]
Enhatch emerged from the founders' extensive experience designing medical implants and instruments at major firms like Stryker Orthopedics and Tornier (now part of Wright Medical), where they launched successful products such as the Scorpio NRG Knee and next-gen shoulder systems for Nexa Orthopedics.[3] Established in 2012 as a privately held, venture-backed medtech startup in Hoboken, New Jersey (with operations in Tulsa, Oklahoma), the company addressed gaps in computer-assisted surgery by creating AI and machine learning tools to automate patient-specific workflows across the surgical continuum.[1][2][3] Early traction came from integrating with enabling technologies, filling workflow voids for medical device makers, and evolving into a comprehensive platform that connects imaging, 3D modeling, implant optimization, and post-op monitoring, with pivotal partnerships like 3D Systems accelerating scalability.[2][5]
Enhatch rides the wave of personalized medicine and additive manufacturing in orthopedics, where AI automates complex, patient-specific workflows amid rising demand for 3D printed implants—over two million produced annually by partners like 3D Systems.[1][2][5] Timing aligns with post-pandemic shifts to efficient, remote surgical planning and integration of robotics/AI, countering market forces like supply chain disruptions and labor shortages in medtech by cutting logistics and enabling lean teams.[2][6] It influences the ecosystem by creating an open platform that unifies siloed technologies, boosting efficiency for device makers (e.g., Stryker alumni roots) and hospitals, while adapting to innovations like in vivo sensors to automate surgery's future.[2][3][5]
Enhatch is poised to expand its Intelligent Surgery Ecosystem through deeper AI enhancements, more FDA clearances, and partnerships scaling personalized devices globally, targeting high-volume procedures beyond knees and spines.[2][4][5] Trends like AI-robotics convergence and value-based care will propel growth, potentially evolving its influence from workflow optimizer to full surgical automation leader, delivering safer outcomes for millions.[2][3] This positions Enhatch as a key enabler in medtech's shift to precision, patient-centric innovation—streamlining what once took weeks into seamless, anatomy-matched plans.[1][6]
